DUBLIN, IRELAND -- (MARKET WIRE) -- October 26, 2006 -- Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB.I), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2006.
